Isolated interacting protein bioinformatics analysis of Survivin in association with esophageal squamous cell carcinoma
Background Survivin is a pivotal anti-apoptotic protein with diverse biological functions beyond apoptosis inhibition in esophageal carcinoma cells. However, systematic screening of Survivin-interacting partners in esophageal cancer remains unreported. Objectives This study was designed to systematically map the Survivin interactome, pinpoint core molecular signatures tightly linked to esophageal squamous cell carcinoma (ESCC) pathogenesis, and decipher their underlying regulatory mechanisms. Methods Survivin-binding proteins were screened and verified via proteomic profiling, co-immunoprecipitation (Co-IP), western blotting (WB), and bioinformatic analyses. Results A total of 1209 putative Survivin interactors were identified in 293T cells, and 31 candidates were validated via WB in both 293T and Eca-109 cell lysates. Functional enrichment showed these interactors were mainly involved in cytoplasmic translation, ribosome biogenesis, RNA splicing, and molecular functions including cadherin, unfolded protein, ribonucleoprotein complex and nucleic acid binding, as well as translational regulator activity. Integrative analysis with ESCC differentially expressed genes (DEGs) identified 36 critical interactors and 9 hub genes. It is noteworthy that among the published research, 12 Survivin-interacting proteins and 3 of the 9 Hub genes have been functionally validated. Conclusion This study provides a comprehensive systematic Survivin interactome profile and identifies ESCC-associated core genes. The findings lay experimental foundations for exploring uncharacterized Survivin regulatory mechanisms in esophageal tumorigenesis and progression, and support the discovery of novel therapeutic targets.
Authors
- Jiwen Liu
- Huiwu Li (ORCID: https://orcid.org/0000-0003-0688-6650)
- Liting Huang
- Heng Zhang
Institutions
- Xinjiang Medical University (CN)
- Shantou University (CN)
- Yue Bei People's Hospital (CN)
Publication Details
- Journal
- Current Proteomics
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1016/j.curpro.2026.100194
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China